These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 30968973

  • 21. Effect of erythropoietin administration on proteins participating in iron homeostasis in Tmprss6-mutated mask mice.
    Frýdlová J, Rychtarčíková Z, Gurieva I, Vokurka M, Truksa J, Krijt J.
    PLoS One; 2017; 12(10):e0186844. PubMed ID: 29073189
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.
    Garrido P, Ribeiro S, Fernandes J, Vala H, Bronze-da-Rocha E, Rocha-Pereira P, Belo L, Costa E, Santos-Silva A, Reis F.
    PLoS One; 2015; 10(4):e0124048. PubMed ID: 25867633
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. The effect of erythroferrone suppression by transfusion on the erythropoietin-erythroferrone-hepcidin axis in transfusion-dependent thalassaemia: A pre-post cohort study.
    Zaman BA, Rasool SO, Abdo JM.
    Br J Haematol; 2023 May; 201(3):547-551. PubMed ID: 36535905
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cardiomyocyte-specific overexpression of FPN1 diminishes cardiac hypertrophy induced by chronic intermittent hypoxia.
    Song JX, Xu S, Chen Q, Gou Y, Zhao CB, Jia CL, Liu H, Zhang Z, Li BL, Gao Y, Zhao Y, Ji ES.
    J Cell Mol Med; 2024 Jul; 28(14):e18543. PubMed ID: 39054575
    [Abstract] [Full Text] [Related]

  • 30. Chronic intermittent hypobaric hypoxia improves markers of iron metabolism in a model of dietary-induced obesity.
    Cui F, Guo J, Hu HF, Zhang Y, Shi M.
    J Inflamm (Lond); 2020 Nov 07; 17(1):36. PubMed ID: 33292270
    [Abstract] [Full Text] [Related]

  • 31. Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project.
    Piperno A, Galimberti S, Mariani R, Pelucchi S, Ravasi G, Lombardi C, Bilo G, Revera M, Giuliano A, Faini A, Mainini V, Westerman M, Ganz T, Valsecchi MG, Mancia G, Parati G, HIGHCARE investigators.
    Blood; 2011 Mar 10; 117(10):2953-9. PubMed ID: 21149632
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Adaptation of iron transport and metabolism to acute high-altitude hypoxia in mountaineers.
    Goetze O, Schmitt J, Spliethoff K, Theurl I, Weiss G, Swinkels DW, Tjalsma H, Maggiorini M, Krayenbühl P, Rau M, Fruehauf H, Wojtal KA, Müllhaupt B, Fried M, Gassmann M, Lutz T, Geier A.
    Hepatology; 2013 Dec 10; 58(6):2153-62. PubMed ID: 23787477
    [Abstract] [Full Text] [Related]

  • 35. Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats.
    Du F, Qian ZM, Luo Q, Yung WH, Ke Y.
    Mol Neurobiol; 2015 Aug 10; 52(1):101-14. PubMed ID: 25115800
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Iron-regulatory gene expression during liver regeneration.
    Mollbrink A, Holmström P, Sjöström M, Hultcrantz R, Eriksson LC, Stål P.
    Scand J Gastroenterol; 2012 May 10; 47(5):591-600. PubMed ID: 22364558
    [Abstract] [Full Text] [Related]

  • 38. Characterization of Putative Erythroid Regulators of Hepcidin in Mouse Models of Anemia.
    Mirciov CS, Wilkins SJ, Dunn LA, Anderson GJ, Frazer DM.
    PLoS One; 2017 May 10; 12(1):e0171054. PubMed ID: 28135344
    [Abstract] [Full Text] [Related]

  • 39. A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients.
    Ogawa C, Tsuchiya K, Tomosugi N, Maeda K.
    Int J Mol Sci; 2020 Sep 28; 21(19):. PubMed ID: 32998272
    [Abstract] [Full Text] [Related]

  • 40. Effects of altitude and recombinant human erythropoietin on iron metabolism: a randomized controlled trial.
    Breenfeldt Andersen A, Bonne TC, Bejder J, Jung G, Ganz T, Nemeth E, Olsen NV, Huertas JR, Nordsborg NB.
    Am J Physiol Regul Integr Comp Physiol; 2021 Aug 01; 321(2):R152-R161. PubMed ID: 34160288
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.